The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail vetinfo@hpra.ie


Cevac MD Rispens concentrate and solvent for suspension for injection for chickens



CEVA-Phylaxia Veterinary Biologicals Co. LtdVPA10463/007/001

Main Information

Trade NameCevac MD Rispens concentrate and solvent for suspension for injection for chickens
Active SubstancesMarek's disease virus strain cvi 988 live
Dosage FormConcentrate and solvent for suspension for injection
Licence HolderCEVA-Phylaxia Veterinary Biologicals Co. Ltd
Licence NumberVPA10463/007/001

Group Information

ATC CodeQI01AD03 avian herpes virus (marek's disease)
Therapeutic ClassImmunological - Live Vaccine
SpeciesChickens

Status

License statusAuthorised
Licence Issued25/08/2020
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation

Documents

Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsNo document available

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back